Quantamental Technologies LLC Theravance Biopharma, Inc. Transaction History

Quantamental Technologies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$8.33 - $12.96 $105,491 - $164,125	-12,664 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$7.42 - $11.05 $93,966 - $139,937	12,664 New	12,664 $140,000
Q1 2019 Apr 29, 2019	SELL	$22.57 - $28.15 $90,280 - $112,600	-4,000 Closed	0 $0
Q4 2018 Jan 28, 2019	BUY	$22.52 - $35.07 $90,080 - $140,280	4,000 New	4,000 $102,000

122

47.3M

200

12.8K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $640M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.